title: Myelinoid bodies in a patient with membranoproliferative glomerulonephritis.
authors.forename: Kirsten
authors.initials: K
authors.lastname: Hills
authors.forename: Hema
authors.initials: H
authors.lastname: Mahajan
authors.forename: Ross
authors.initials: R
authors.lastname: Boadle
authors.forename: Brian
authors.initials: B
authors.lastname: Nankivell
authors.forename: Jim L C
authors.initials: JL
authors.lastname: Yong
authors.forename: Chow Heok
authors.initials: CH
authors.lastname: P'ng
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D001650:Bile Duct Neoplasms / Q000150:complications / Q000188:drug therapy; D001653:Bile Ducts, Intrahepatic / Q000473:pathology; D018281:Cholangiocarcinoma / Q000150:complications / Q000188:drug therapy; D003841:Deoxycytidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D015432:Glomerulonephritis, Membranoproliferative / Q000150:complications / Q000473:pathology*; D006801:Humans; D002479:Inclusion Bodies / Q000648:ultrastructure*; D007678:Kidney Glomerulus / Q000648:ultrastructure*; D008297:Male; D046529:Microscopy, Electron, Transmission; D008875:Middle Aged; D000093542:Gemcitabine
chemical_list: D000970:Antineoplastic Agents; D003841:Deoxycytidine; D000093542:Gemcitabine